| 4 0.02 (0.5%) | 07-31 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 6.39  |
1-year : | 7.81 |
| Resists | First : | 5.47 |
Second : | 6.69 |
| Pivot price | 4.07 |
|||
| Supports | First : | 3.5 | Second : | 2.92 |
| MAs | MA(5) : | 3.86  |
MA(20) : | 4.34 |
| MA(100) : | 5.42 |
MA(250) : | 6.9 |
|
| MACD | MACD : | -0.6 |
Signal : | -0.6 |
| %K %D | K(14,3) : | 19.4 |
D(3) : | 14.2 |
| RSI | RSI(14): 38.7 |
|||
| 52-week | High : | 14.48 | Low : | 3.5 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ ASPI ] has closed above bottom band by 43.7%. Bollinger Bands are 41.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 4.15 - 4.17 | 4.17 - 4.19 |
| Low: | 3.82 - 3.83 | 3.83 - 3.85 |
| Close: | 3.97 - 4 | 4 - 4.03 |
ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters in Boca Raton, Florida.
Tue, 28 Jul 2026
ASP Isotopes Schedules Capital Markets Day in London for September 8, 2026 - Kalkine Media
Tue, 28 Jul 2026
ASP Isotopes to Detail Nuclear Medicine, Fuels at Sept. 8 Event - Stock Titan
Sun, 19 Jul 2026
Reframing ASP Isotopes' (ASPI) Long-Term Strategy - Yahoo Finance
Fri, 17 Jul 2026
Is ASP Isotopes' (ASPI) New Shelf Registration Reframing Its Long‑Term Capital Strategy? - simplywall.st
Wed, 15 Jul 2026
ASP Isotopes Announces Agreements to Exchange Certain QLE Convertible Notes for ASPI Common Stock - GlobeNewswire
Thu, 02 Jul 2026
ASP Isotopes (ASPI) CFO sells 23,124 shares to cover RSU taxes - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Basic Materials
|
|
|
Industry:
Chemicals
|
|
| Shares Out | 126 (M) |
| Shares Float | 109 (M) |
| Held by Insiders | 11 (%) |
| Held by Institutions | 48.5 (%) |
| Shares Short | 24,240 (K) |
| Shares Short P.Month | 23,090 (K) |
| EPS | -2.22 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.29 |
| Profit Margin | 0 % |
| Operating Margin | -595.5 % |
| Return on Assets (ttm) | -13.7 % |
| Return on Equity (ttm) | -103.4 % |
| Qtrly Rev. Growth | 279.2 % |
| Gross Profit (p.s.) | 0.03 |
| Sales Per Share | 0.21 |
| EBITDA (p.s.) | -0.56 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -52 (M) |
| Levered Free Cash Flow | -40 (M) |
| PE Ratio | -1.81 |
| PEG Ratio | 0 |
| Price to Book value | 1.73 |
| Price to Sales | 18.7 |
| Price to Cash Flow | -9.62 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|